clinical trial · NCT04072315
Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
Idiopathic Pulmonary FibrosisPLN-74809Knottin tracer
brief summary
A study in mild/moderate IPF patients using an αVβ6 PET ligand to evaluate target engagement.
started
Feb 13, 2020
primary completion
Jun 27, 2022
completion
Jul 5, 2022
last updated
Dec 12, 2023
official title
A Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol